Simply sign up* for your Promo Code
The expression of nutrient transporters, such as GLUT1 and LAT1, has been shown to be high in both, the BBB and in glioma (207, 208), which led to the development of different transporter-utilizing anti-cancer drug delivery strategies in order to reach the cancer cells residing beyond the intact BBB (Table II)
7 Hypoglycemia (Low blood glucose) Risk: While GLP-1 agonists have a lower risk of causing hypoglycemia compared to other diabetes medications, the risk increases significantly when they are used in combination with insulin or sulfonylureas, which actively lower blood sugar
Approximately 25% of GSS deficiency patients succumb to the disorder in the neonatal period as a result of bacterial infections and severe metabolic acidosis
Cavalieri EL, Stack DE, Devanesan PD, Todorovic R, Dwivedy I, Higginbotham S et al
Personalized, supervised dosing produces steadier, safer outcomes, while chasing a larger dose from an unverified source raises risk without improving results
